Genetic Technologies Ltd (NASDAQ:GENE)

3.70
Delayed Data
As of Mar 27
 +0.01 / +0.27%
Today’s Change
1.04
Today|||52-Week Range
11.00
+92.16%
Year-to-Date
Institutional investors purchased a net $2.3 million shares of GENE during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 28.48% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/06/2015SABBY CAPITAL LLC  Bought 1.1 Million shares of Genetic Technologies Ltd
3/06/2015HEIGHTS CAPITAL MANAGEMENT, INC.  Bought 1.1 Million shares of Genetic Technologies Ltd
12/31/2014RENAISSANCE TECHNOLOGIES LLC  Bought 37.0 Thousand shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC13.73%1,111,1116,477,777+1,111,111--
Heights Capital Management, Inc.13.73%1,111,1116,477,777+1,111,111--
Renaissance Technologies LLC0.73%58,800342,804+37,040+170.22%
Thompson Davis & Co., Inc.0.17%13,80080,454+13,800--
Columbia Management Investment Ad...0.06%4,58226,713+1,652+56.38%
KCG Americas LLC0.05%3,93922,964-10,810-73.29%
Alpine Securities USVI LLC0.03%2,22012,94300.00%
Morgan Stanley & Co. LLC0.00%423+1+33.33%
Citadel Advisors LLC0.00%00-2,955-100.00%
Jane Street Capital LLC0.00%00-2,943-100.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change

To view my watchlist

Not a member yet?

Sign up now for a free account